Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 898Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2024/11/12/2979112/0/en/Enlivex-Announces-the-Enrollment-and-Dosing-of-the-First-10-Patient-in-the-Randomized-Phase-II-Stage-of-its-Allocetra-Trial-in-Patients-with-Moderate-to-Severe-Knee-Osteoarthritis.html

GLOBENEWSWIRE
12 Nov 2024

https://www.globenewswire.com/news-release/2024/11/04/2974018/0/en/Centers-for-Medicare-and-Medicaid-Services-CMS-Establishes-Additional-Payment-for-iovera-in-Outpatient-Settings.html

GLOBENEWSWIRE
04 Nov 2024

https://www.globenewswire.com/news-release/2024/10/03/2957673/0/en/Pacira-BioSciences-Announces-New-Product-Specific-J-Code-for-EXPAREL-Effective-January-1-2025.html

GLOBENEWSWIRE
03 Oct 2024

https://www.prnewswire.com/news-releases/heron-therapeutics-announces-fda-approval-of-the-prior-approval-supplement-application-for-zynrelef-vial-access-needle-van-302258083.html

PR NEWSWIRE
25 Sep 2024

https://www.globenewswire.com/news-release/2024/09/09/2943191/0/en/Pacira-BioSciences-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-C-4.html

GLOBENEWSWIRE
09 Sep 2024

https://www.prnewswire.com/news-releases/heron-therapeutics-announces-the-inclusion-of-zynrelef-as-a-qualifying-product-under-the-proposed-2025-non-opioid-policy-for-pain-relief-under-the-opps-and-the-asc-payment-system-302196793.html

PR NEWSWIRE
15 Jul 2024